CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
10 hedge funds and large institutions have $20.4M invested in Celyad Oncology SA American Depositary Shares in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+5
Holders Change %
+100%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$5.2M |
| 2 |
Jane Street
New York
|
+$260K |
| 3 |
Renaissance Technologies
New York
|
+$227K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$150K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.61K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$191K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $19.5M | +$5.2M | +118,590 | +36% |
|
|
2
Morgan Stanley
New York
| $265K | -$191K | -4,425 | -42% |
|
|
3
Jane Street
New York
| $260K | +$260K | +6,254 | New |
|
|
4
Renaissance Technologies
New York
| $227K | +$227K | +5,260 | New |
|
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $150K | +$150K | +3,500 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $46K | +$7.61K | +173 | +20% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $6K | +$4.82K | +119 | +410% |
|
8
Zurich Cantonal Bank
Zurich,
Switzerland
| $4K | – | – | – |
|
9
Bank of Montreal
Toronto,
Ontario, Canada
| $4K | +$4K | +87 | New |
|
|
II
10
Inspire Investing
Meridian,
Idaho
| $1K | +$1K | +21 | New |
|